MGMT and central nervous system cancer: It is compatible with Illumina Novaseq 6000 (JAX SOMASEQ - Clinical test - NIH Genetic Testing Registry GTR - NCBI, 2023) and could be used for the diagnosis of glioma, however, it misses p-TERT DNA sequence alterations, p-MGMT methylation, and important CNVs such as 1p/19q codeletion.